Form 4: Director Robert Adams Receives NHC Stock Option Grant

Sentiment:

Statement of Changes in Beneficial Ownership


National HealthCare Corp director Robert Adams was granted 7,500 stock options as part of the company's 2020 Omnibus Equity Incentive Plan.

Summary

  • Director Robert G. Adams received a grant of 7,500 stock options for National HealthCare Corp (NHC) common stock.
  • The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
  • The options vest beginning May 7, 2027, and expire on May 6, 2031.
  • The reporting person maintains indirect beneficial ownership of 430,341 shares as a General Partner and 13,579 shares as a Trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.
  • Standardized incentive structure under the 2020 Omnibus Equity Incentive Plan.

Negatives

  • Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

  • Market price volatility affecting the value of the granted options.
  • Regulatory and compliance risks associated with Section 16 reporting requirements.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director equity compensation.

Management Comments

  • The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure long-term alignment with shareholder interests.

Comparison to Industry Standards

  • The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
  • The grant size and vesting schedule are typical for non-executive director compensation packages in the mid-cap healthcare space.

Stakeholder Impact

  • Shareholders may experience minor dilution if options are exercised in the future.

Next Steps

  • Vesting of the granted options on May 7, 2027.

Key Dates

DateDescription
05/07/2026Grant date of the stock options and date of the reported transaction.
05/07/2027Date the 2026 grant options become exercisable.
05/06/2031Expiration date of the 2026 stock option grant.

Keywords

National HealthCare Corp, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.